GOSS
Gossamer Bio, Inc.
Company overview
- Market capitalization
- —
- Employees
- 161
- Latest publication
- 2026-09-29
About Gossamer Bio, Inc.
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 9,238,000USD | 16,955,000USD | 13,799,000USD | 13,294,000USD | 11,489,000USD | 9,889,000USD | 9,379,000USD | 9,480,000USD |
| Research Development | 26,412,000USD | 43,070,000USD | 48,935,000USD | 53,018,000USD | 41,575,000USD | 38,041,000USD | 36,112,000USD | 34,897,000USD |
| Selling General Administrative | 8,900,000USD | 18,746,000USD | 10,904,000USD | 9,390,000USD | 8,679,000USD | 8,658,000USD | 9,395,000USD | 8,502,000USD |
| General And Administrative Expenses | 8,900,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 35,312,000USD | 61,589,000USD | 59,839,000USD | 62,408,000USD | 50,254,000USD | 46,699,000USD | 45,507,000USD | 43,399,000USD |
| Operating Income | -26,074,000USD | -44,866,000USD | -46,040,000USD | -49,114,000USD | -38,765,000USD | -36,810,000USD | -36,128,000USD | -33,919,000USD |
| Total Other Income Expense Net | 42,974,000USD | -1,798,000USD | -1,286,000USD | 893,000USD | 492,000USD | 172,000USD | 689,000USD | 1,984,000USD |
| Interest Income | 268,000USD | 354,000USD | 447,000USD | 687,000USD | 542,000USD | 294,000USD | 744,000USD | 430,000USD |
| Interest Expense | 2,705,000USD | 2,755,000USD | 2,751,000USD | 2,748,000USD | 2,744,000USD | 2,746,000USD | 2,738,000USD | 2,734,000USD |
| Net Income | 16,900,000USD | -46,664,000USD | -47,238,000USD | -48,221,000USD | -38,273,000USD | -36,638,000USD | -33,029,000USD | -30,803,000USD |
| Net Income Applicable To Common Shares | -25,168,000USD | — | — | — | — | — | — | — |
| Cost Of Revenue | — | 232,000USD | 227,000USD | — | — | — | 1,075,000USD | — |
| Gross Profit | — | 16,722,999USD | 13,799,000USD | 13,294,000USD | 11,489,000USD | 9,889,000USD | 9,379,000USD | 9,480,000USD |
| Net Interest Income | — | -2,401,000USD | -2,304,000USD | -2,061,000USD | -2,202,000USD | -2,452,000USD | -3,482,000USD | -2,304,000USD |
| Income Before Tax | — | -46,664,000USD | -47,326,000USD | -48,221,000USD | -38,273,000USD | -36,638,000USD | -35,439,000USD | -31,935,000USD |
| Net Income From Continuing Ops | — | -46,664,000USD | -47,238,000USD | -48,221,000USD | -38,273,000USD | -36,638,000USD | -33,029,000USD | -30,803,000USD |
| Ebit | — | -43,909,000USD | -44,575,000USD | -45,473,000USD | -35,529,000USD | -33,892,000USD | -32,701,000USD | -29,201,000USD |
| Ebitda | — | -43,677,000USD | -44,348,000USD | -45,467,000USD | -35,316,000USD | -33,550,000USD | -31,626,000USD | -28,103,000USD |
| Depreciation And Amortization | — | 232,000USD | 227,000USD | 6,000USD | 213,000USD | 342,000USD | 1,075,000USD | 1,098,000USD |
| Reconciled Depreciation | — | 232,000USD | 227,000USD | 220,000USD | 213,000USD | 342,000USD | 1,075,000USD | 1,098,000USD |
| Income Tax Expense | — | — | -88,000USD | — | — | — | -2,410,000USD | -1,132,000USD |
| Tax Provision | — | — | -88,000USD | 0USD | 0USD | — | -2,410,000USD | -1,132,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20192019-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|---|
| Total Revenue | 48,471,000USD | 114,701,000USD | 0USD | 0USD |
| Cost Of Revenue | 1,002,000USD | 4,151,000USD | 3,089,000USD | 0USD |
| Gross Profit | 47,469,000USD | 114,701,000USD | -3,089,000USD | 0USD |
| Research Development | 174,093,000USD | 138,487,000USD | 143,403,000USD | 0USD |
| Selling General Administrative | 37,631,000USD | 36,133,000USD | 39,136,000USD | 83,000USD |
| Total Operating Expenses | 210,722,000USD | 174,620,000USD | 182,539,000USD | 83,000USD |
| Operating Income | -163,253,000USD | -59,919,000USD | -186,139,000USD | -83,000USD |
| Interest Income | 1,970,000USD | 1,779,000USD | — | 0USD |
| Interest Expense | 10,989,000USD | 11,517,000USD | 0USD | 0USD |
| Net Interest Income | -9,019,000USD | -9,738,000USD | — | 0USD |
| Income Before Tax | -170,458,000USD | -55,635,000USD | -180,307,000USD | -83,000USD |
| Income Tax Expense | -88,000USD | 893,000USD | 511,000USD | -83,000USD |
| Tax Provision | -88,000USD | 893,000USD | — | — |
| Net Income | -170,370,000USD | -56,528,000USD | -180,818,000USD | -83,000USD |
| Net Income From Continuing Ops | -170,370,000USD | -56,528,000USD | -180,307,000USD | -83,000USD |
| Ebit | -159,469,000USD | -44,118,000USD | -182,539,000USD | -83,000USD |
| Ebitda | -158,467,000USD | -39,967,000USD | -179,450,000USD | -83,000USD |
| Depreciation And Amortization | 1,002,000USD | 4,151,000USD | 3,089,000USD | 83,000USD |
| Reconciled Depreciation | 1,002,000USD | 4,151,000USD | 3,089,000USD | — |
| Total Other Income Expense Net | -7,205,000USD | 4,284,000USD | 5,832,000USD | 0USD |
| Non Operating Income Net Other | — | — | 5,832,000USD | — |
| Net Income Applicable To Common Shares | — | — | -180,307,000USD | -83,000USD |
| Other Operating Expenses | — | — | — | 83,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 76,867,000USD | 128,899,000USD | 172,249,000USD | 208,820,000USD | 240,925,000USD | 280,589,000USD | 315,292,000USD | 350,879,000USD |
| Cash And Equivalents | 41,148,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 57,026,000USD | 99,215,000USD | 136,932,000USD | 180,224,000USD | 212,918,000USD | 257,934,000USD | 294,518,000USD | 327,034,000USD |
| Short Term Investments | 15,878,000USD | 58,187,000USD | 99,200,000USD | 171,291,000USD | 186,609,000USD | 228,913,000USD | 248,444,000USD | 298,570,000USD |
| Total Current Assets | 72,725,000USD | 124,536,000USD | 167,644,000USD | 203,989,000USD | 235,898,000USD | 275,475,000USD | 309,888,000USD | 344,268,000USD |
| Other Current Assets | 9,594,000USD | 15,969,000USD | 18,185,000USD | 14,122,000USD | 15,001,000USD | 10,958,000USD | 10,032,000USD | 10,646,000USD |
| Other Non Current Assets | 429,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 170,896,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 137,783,000USD | 56,506,000USD | 63,435,000USD | 62,117,000USD | 53,594,000USD | 48,223,000USD | 45,010,000USD | 51,085,000USD |
| Other Current Liabilities | 17,710,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | -94,029,000USD | -161,483,000USD | -122,760,000USD | -82,333,000USD | -46,107,000USD | -6,250,000USD | 29,492,000USD | 54,136,000USD |
| Total Equity Including Noncontrolling Interest | -94,029,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 7,068,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 30,155,000USD | — | — | — | — | — | — | — |
| Net Receivables | 6,105,000USD | 9,352,000USD | 12,527,000USD | 9,643,000USD | 7,979,000USD | 6,583,000USD | 5,338,000USD | 6,588,000USD |
| Property Plant Equipment Net | 3,713,000USD | 3,965,000USD | 4,197,000USD | 4,424,000USD | 4,644,000USD | 4,804,000USD | 5,121,000USD | 6,328,000USD |
| Accounts Payable | 5,951,000USD | 10,822,000USD | 5,959,000USD | 1,116,000USD | 1,876,000USD | 3,389,000USD | 2,319,000USD | 3,057,000USD |
| Short Term Debt | 965,000USD | 957,000USD | 938,000USD | 919,000USD | 890,000USD | 853,000USD | 961,000USD | 1,748,000USD |
| Common Stock | 50,000USD | 24,000USD | 24,000USD | 24,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD |
| Retained Earnings | -1,468,702,000USD | -1,485,602,000USD | -1,438,938,000USD | -1,391,700,000USD | -1,343,479,000USD | -1,305,206,000USD | -1,268,568,000USD | -1,235,539,000USD |
| Accumulated Other Comprehensive Income | -3,734,000USD | -4,024,000USD | -5,149,000USD | -5,107,000USD | -5,088,000USD | -824,000USD | 1,189,000USD | -2,231,000USD |
| Total Liab | — | 290,382,000USD | 295,009,000USD | 291,153,000USD | 287,032,000USD | 286,839,000USD | 285,800,000USD | 296,743,000USD |
| Other Current Liab | — | 35,986,000USD | 36,551,000USD | 36,108,000USD | 27,356,000USD | 26,127,000USD | 24,680,000USD | 24,850,000USD |
| Capital Stock | — | 24,000USD | 24,000USD | 24,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD |
| Cash | — | 41,028,000USD | 37,732,000USD | 8,933,000USD | 26,309,000USD | 29,021,000USD | 46,074,000USD | 28,464,000USD |
| Current Deferred Revenue | — | 8,741,000USD | 19,987,000USD | 23,974,000USD | 23,472,000USD | 17,854,000USD | 17,050,000USD | 20,327,000USD |
| Net Debt | — | 161,905,000USD | 165,174,000USD | 193,943,000USD | 176,524,000USD | 173,766,000USD | 156,808,000USD | 175,162,000USD |
| Short Long Term Debt Total | — | 202,933,000USD | 202,906,000USD | 202,876,000USD | 202,833,000USD | 202,787,000USD | 202,882,000USD | 203,626,000USD |
| Long Term Debt | — | 198,763,000USD | 198,508,000USD | 198,257,000USD | 198,009,000USD | 197,764,000USD | 197,523,000USD | 197,285,000USD |
| Property Plant Equipment Gross | — | 3,965,000USD | 4,404,000USD | 4,424,000USD | 4,644,000USD | 4,804,000USD | 5,304,000USD | 10,053,000USD |
| Common Stock Shares Outstanding | — | 234,137,364shares | 226,604,138shares | 227,981,475shares | 227,275,466shares | 226,818,051shares | 226,604,138shares | 226,346,058shares |
| Non Current Assets Total | — | 4,363,000USD | 4,605,000USD | 4,830,999USD | 5,027,000USD | 5,114,000USD | 5,404,000USD | 6,611,000USD |
| Non Current Liabilities Total | — | 233,876,000USD | 231,574,000USD | 229,036,000USD | 233,438,000USD | 238,616,000USD | 240,790,000USD | 245,658,000USD |
| Non Currrent Assets Other | — | 398,000USD | 408,000USD | 406,999USD | 383,000USD | 310,000USD | 283,000USD | 283,000USD |
| Net Working Capital | — | 68,030,000USD | 104,209,000USD | 141,872,000USD | 182,304,000USD | 227,252,000USD | 264,878,000USD | 293,183,000USD |
| Unclassified Non Current Liabilities | — | 35,113,000USD | 33,066,000USD | 30,779,000USD | 35,429,000USD | 40,852,000USD | 43,267,000USD | 48,373,000USD |
| Unclassified Equity | — | 1,328,095,000USD | 1,321,279,000USD | 1,314,426,000USD | 1,302,414,000USD | 1,299,734,000USD | 1,296,825,000USD | 1,291,860,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | — | 1,103,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 172,249,000USD | 315,292,000USD | 311,916,000USD | 272,450,000USD | 343,657,000USD | 539,433,000USD | 426,604,000USD | 239,419,000USD |
| Other Current Assets | 18,185,000USD | 10,032,000USD | 10,094,000USD | 6,202,000USD | 6,562,000USD | 9,694,000USD | 7,551,000USD | 3,295,000USD |
| Total Liab | 295,009,000USD | 285,800,000USD | 249,147,000USD | 260,373,000USD | 222,194,000USD | 218,749,000USD | 74,119,000USD | 359,488,000USD |
| Total Stockholder Equity | -122,760,000USD | 29,492,000USD | 62,769,000USD | 12,077,000USD | 121,463,000USD | 320,684,000USD | 352,485,000USD | -120,069,000USD |
| Other Current Liab | 36,551,000USD | 24,680,000USD | 31,157,000USD | 33,175,000USD | 33,713,000USD | 27,509,000USD | 33,613,000USD | 18,221,000USD |
| Common Stock | 24,000USD | 23,000USD | 23,000USD | 10,000USD | 8,000USD | 8,000USD | 7,000USD | 2,000USD |
| Capital Stock | 24,000USD | 23,000USD | 23,000USD | 10,000USD | 8,000USD | 8,000USD | 7,000USD | 2,000USD |
| Retained Earnings | -1,438,938,000USD | -1,268,568,000USD | -1,212,040,000USD | -1,032,223,000USD | -811,534,000USD | -577,530,000USD | -334,170,000USD | -153,863,000USD |
| Cash | 37,732,000USD | 46,074,000USD | 32,109,000USD | 111,973,000USD | 183,403,000USD | 486,055,000USD | 135,026,000USD | 105,219,000USD |
| Cash And Short Term Investments | 136,932,000USD | 294,518,000USD | 296,425,000USD | 255,678,000USD | 325,218,000USD | 512,628,000USD | 401,766,000USD | 228,658,000USD |
| Total Current Assets | 167,644,000USD | 309,888,000USD | 306,519,000USD | 261,880,000USD | 331,780,000USD | 522,322,000USD | 409,317,000USD | 231,953,000USD |
| Total Current Liabilities | 63,435,000USD | 45,010,000USD | 51,598,000USD | 49,230,000USD | 39,859,000USD | 38,650,000USD | 36,923,000USD | 20,403,000USD |
| Current Deferred Revenue | 19,987,000USD | 17,050,000USD | — | — | — | — | — | — |
| Net Debt | 165,174,000USD | 156,808,000USD | 180,355,000USD | 113,766,000USD | 1,834,000USD | -302,323,000USD | -95,476,000USD | -105,219,000USD |
| Short Term Debt | 938,000USD | 961,000USD | 14,915,000USD | 14,596,000USD | 2,902,000USD | 3,633,000USD | 2,354,000USD | — |
| Short Long Term Debt Total | 202,906,000USD | 202,882,000USD | 212,464,000USD | 225,739,000USD | 185,237,000USD | 183,732,000USD | 39,550,000USD | — |
| Long Term Debt | 198,508,000USD | 197,523,000USD | 197,405,000USD | 207,697,000USD | 179,117,000USD | 172,386,000USD | 28,459,000USD | — |
| Short Term Investments | 99,200,000USD | 248,444,000USD | 264,316,000USD | 143,705,000USD | 141,815,000USD | 26,573,000USD | 266,740,000USD | 123,439,000USD |
| Net Receivables | 12,527,000USD | 5,338,000USD | — | — | 200,000USD | 200,000USD | 1,500,000USD | 500,000USD |
| Accounts Payable | 5,959,000USD | 2,319,000USD | 5,526,000USD | 1,459,000USD | 3,244,000USD | 7,508,000USD | 956,000USD | 2,182,000USD |
| Property Plant Equipment Net | 4,197,000USD | 5,121,000USD | 4,779,000USD | 9,890,000USD | 10,797,000USD | 16,084,000USD | 15,728,000USD | 3,193,000USD |
| Property Plant Equipment Gross | 4,404,000USD | 5,304,000USD | 10,211,000USD | 16,002,000USD | 15,077,000USD | 16,084,000USD | 15,728,000USD | 3,193,000USD |
| Accumulated Other Comprehensive Income | -5,149,000USD | 1,189,000USD | -350,000USD | -574,000USD | 45,000USD | 599,000USD | 258,000USD | -61,000USD |
| Common Stock Shares Outstanding | 228,519,130shares | 226,228,016shares | 225,572,276shares | 84,574,869shares | 74,843,482shares | 68,510,260shares | 54,740,170shares | 60,401,910shares |
| Non Current Assets Total | 4,605,000USD | 5,404,000USD | 5,397,000USD | 10,570,000USD | 11,877,000USD | 17,111,000USD | 17,287,000USD | 7,466,000USD |
| Non Current Liabilities Total | 231,574,000USD | 240,790,000USD | 197,549,000USD | 211,143,000USD | 182,335,000USD | 180,099,000USD | 37,196,000USD | 339,085,000USD |
| Non Currrent Assets Other | 408,000USD | 283,000USD | 618,000USD | 680,000USD | 1,080,000USD | 1,027,000USD | 1,559,000USD | 4,273,000USD |
| Net Working Capital | 104,209,000USD | 264,878,000USD | 254,921,000USD | 212,650,000USD | 291,921,000USD | 483,672,000USD | 372,394,000USD | 211,550,000USD |
| Unclassified Non Current Liabilities | 33,066,000USD | 43,267,000USD | — | -195,709,000USD | -150,038,000USD | -143,642,000USD | — | 336,267,000USD |
| Unclassified Equity | 1,321,279,000USD | 1,296,825,000USD | 1,275,113,000USD | 1,044,854,000USD | 932,936,000USD | 897,599,000USD | 686,383,000USD | 33,851,000USD |
| Other Assets | — | — | 1USD | 680,000USD | 1,080,000USD | 1,027,000USD | 1,559,000USD | 4,273,000USD |
| Short Long Term Debt | — | — | 11,613,000USD | 11,613,000USD | — | — | — | — |
| Unclassified Current Liabilities | — | — | -11,613,000USD | -11,613,000USD | — | — | — | — |
| Non Current Liabilities Other | — | — | — | 199,155,000USD | 153,256,000USD | 151,355,000USD | 8,737,000USD | — |
| Net Tangible Assets | — | — | — | 12,077,000USD | 121,463,000USD | 320,684,000USD | 352,485,000USD | -120,069,000USD |
| Inventory | — | — | — | — | -136,000USD | 365,000USD | -1,500,000USD | — |
| Unclassified Non Current Assets | — | — | — | — | -1,080,000USD | -1,027,000USD | -1,559,000USD | -4,273,000USD |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 2,100,000USD |
| Other Liab | — | — | — | — | — | — | — | 718,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 9,000USD |
| Stock Based Compensation | 8,767,000USD |
| Other Non Cash Items | 43,846,000USD |
| Change To Liabilities | 168,000USD |
| Change In Working Capital | 8,284,000USD |
| Operating Cash Flow | -78,145,000USD |
| Capital Expenditures | 0USD |
| Net Investments | -24,994,000USD |
| Unclassified Investing Cash Flow | 109,300,000USD |
| Investing Cash Flow | 84,306,000USD |
| Common Stock Issuance | 292,000USD |
| Unclassified Financing Cash Flow | -2,924,000USD |
| Financing Cash Flow | -2,632,000USD |
| Effect Of Forex Changes On Cash | -113,000USD |
| Change In Cash | 3,416,000USD |
| End Cash Flow | 41,148,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -46,664,000USD | -47,238,000USD | -48,221,000USD | -38,273,000USD | -36,638,000USD | -33,029,000USD | -30,803,000USD | 49,232,000USD |
| Depreciation | 232,000USD | 227,000USD | 220,000USD | 213,000USD | 342,000USD | 1,075,000USD | 1,082,000USD | 992,000USD |
| Stock Based Compensation | 6,304,000USD | 2,898,000USD | 2,666,000USD | 2,586,000USD | 2,405,000USD | 4,965,000USD | 4,842,000USD | 5,001,000USD |
| Other Non Cash Items | -405,000USD | -837,000USD | 6,139,000USD | -1,699,000USD | -2,426,000USD | -2,941,000USD | 1,739,000USD | -2,672,000USD |
| Change To Account Receivables | 2,975,000USD | -2,984,000USD | -1,664,000USD | -996,000USD | -1,245,000USD | 1,250,000USD | -2,959,000USD | -3,629,000USD |
| Change In Working Capital | 1,812,000USD | -3,364,000USD | 3,029,000USD | -9,888,000USD | -3,407,000USD | -5,551,000USD | -4,051,000USD | 63,795,000USD |
| Total Cash From Operating Activities | -38,721,000USD | -48,314,000USD | -36,167,000USD | -47,061,000USD | -39,724,000USD | -35,481,000USD | -32,033,000USD | 116,348,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | -53,000USD | -26,000USD | 0USD | -32,033,000USD | -116,348,000USD |
| Free Cash Flow | -38,721,000USD | -48,314,000USD | -36,167,000USD | -47,114,000USD | -39,750,000USD | -35,481,000USD | -32,033,000USD | 116,348,000USD |
| Investments | 41,606,000USD | 73,156,000USD | 17,014,000USD | 44,126,000USD | 22,062,000USD | 53,216,000USD | -26,754,000USD | -59,112,000USD |
| Total Cashflows From Investing Activities | 41,606,000USD | 73,156,000USD | 17,014,000USD | 44,126,000USD | 22,062,000USD | 53,216,000USD | -26,754,000USD | -59,112,000USD |
| Total Cash From Financing Activities | 512,000USD | 3,955,000USD | 1,872,000USD | 94,000USD | 504,000USD | 0USD | 281,000USD | -9,214,000USD |
| Sale Purchase Of Stock | 292,000USD | — | 469,000USD | — | 372,000USD | — | 281,000USD | — |
| Change In Cash | 3,296,000USD | 28,799,000USD | -17,376,000USD | -2,712,000USD | -17,053,000USD | 17,610,000USD | -58,413,000USD | 48,014,000USD |
| Begin Period Cash Flow | 37,732,000USD | 8,933,000USD | 26,309,000USD | 29,021,000USD | 46,074,000USD | 28,464,000USD | 86,877,000USD | 38,863,000USD |
| End Period Cash Flow | 41,028,000USD | 37,732,000USD | 8,933,000USD | 26,309,000USD | 29,021,000USD | 46,074,000USD | 28,464,000USD | 86,877,000USD |
| Other Cashflows From Financing Activities | 512,000USD | — | 1,872,000USD | 94,000USD | 504,000USD | — | 281,000USD | 464,000USD |
| Net Borrowings | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Unclassified Financing Cash Flow | — | 3,955,000USD | — | — | — | — | — | -9,678,000USD |
| Issuance Of Capital Stock | — | — | — | — | — | 0USD | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | -116,348,000USD | -59,112,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | -4,842,000USD | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | 148,381,000USD | 175,460,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -170,370,000USD | -56,528,000USD | -179,817,000USD | -229,378,000USD | -234,004,000USD | -243,360,000USD | -180,307,000USD | -146,969,000USD |
| Depreciation | 1,002,000USD | 4,151,000USD | 4,385,000USD | 4,429,000USD | 5,167,000USD | 4,268,000USD | 3,089,000USD | 297,000USD |
| Stock Based Compensation | 10,555,000USD | 20,619,000USD | 28,518,000USD | 42,553,000USD | 32,008,000USD | 38,748,000USD | 20,819,000USD | 30,947,000USD |
| Other Non Cash Items | 1,177,000USD | -11,170,000USD | 2,597,000USD | -177,000USD | 7,165,000USD | 27,237,000USD | 1,445,000USD | 49,659,000USD |
| Change To Account Receivables | -6,889,000USD | -5,338,000USD | — | — | — | — | — | — |
| Change In Working Capital | -13,630,000USD | 39,460,000USD | -14,841,000USD | -4,459,000USD | 774,000USD | -3,095,000USD | 10,120,000USD | 15,022,000USD |
| Total Cash From Operating Activities | -171,266,000USD | -3,468,000USD | -159,158,000USD | -187,032,000USD | -188,890,000USD | -176,360,000USD | -144,834,000USD | -51,044,000USD |
| Capital Expenditures | -79,000USD | 0USD | 0USD | -475,000USD | -1,621,000USD | -24,883,000USD | -6,566,000USD | -21,211,000USD |
| Free Cash Flow | -171,345,000USD | -3,468,000USD | -159,158,000USD | -187,507,000USD | -190,511,000USD | -201,243,000USD | -151,400,000USD | -72,255,000USD |
| Investments | 156,437,000USD | 29,023,000USD | -88,140,000USD | -560,000USD | -115,806,000USD | 240,225,000USD | -140,578,000USD | -123,500,000USD |
| Total Cashflows From Investing Activities | 156,358,000USD | 29,023,000USD | -110,970,000USD | -1,035,000USD | -117,427,000USD | 215,342,000USD | -147,144,000USD | -144,711,000USD |
| Net Borrowings | 0USD | -12,581,000USD | -11,613,000USD | -5,806,000USD | -5,806,000USD | 193,596,000USD | 28,222,000USD | -40,000USD |
| Total Cash From Financing Activities | 6,425,000USD | -11,488,000USD | 190,154,000USD | 117,090,000USD | 3,329,000USD | 312,540,000USD | 321,578,000USD | 300,859,000USD |
| Issuance Of Capital Stock | 0USD | 0USD | 201,341,000USD | 119,946,000USD | 0USD | 117,110,000USD | 291,311,000USD | 303,043,000USD |
| Change In Cash | -8,342,000USD | 13,965,000USD | -79,864,000USD | -71,494,000USD | -303,153,000USD | 351,531,000USD | 29,670,000USD | 105,104,000USD |
| Begin Period Cash Flow | 46,074,000USD | 32,109,000USD | 111,973,000USD | 183,467,000USD | 486,620,000USD | 135,089,000USD | 105,419,000USD | 315,000USD |
| End Period Cash Flow | 37,732,000USD | 46,074,000USD | 32,109,000USD | 111,973,000USD | 183,467,000USD | 486,620,000USD | 135,089,000USD | 105,419,000USD |
| Unclassified Financing Cash Flow | 6,425,000USD | — | 200,435,000USD | -2,950,000USD | 2,477,000USD | — | — | -303,043,000USD |
| Sale Purchase Of Stock | — | 629,000USD | 444,000USD | 122,896,000USD | 3,329,000USD | 117,644,000USD | 293,356,000USD | 303,043,000USD |
| Other Cashflows From Financing Activities | — | 1,093,000USD | 888,000USD | 2,950,000USD | 3,329,000USD | 1,834,000USD | 2,045,000USD | 300,899,000USD |
| Unclassified Investing Cash Flow | — | — | -22,830,000USD | — | — | 23,380,000USD | 3,600,000USD | -17,721,000USD |
| Change To Liabilities | — | — | — | -1,855,000USD | -3,998,000USD | 9,692,000USD | 5,302,000USD | 2,085,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -70,977,000USD | -302,988,000USD | 351,522,000USD | 29,600,000USD | — |
| Other Cashflows From Investing Activities | — | — | — | 65,000USD | -75,000USD | -23,380,000USD | -3,600,000USD | 17,721,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.